Home > National Drug Code (NDC) > Carbidopa and Levodopa

Carbidopa and Levodopa - 0378-1133-01 - (carbidopa and levodopa)

Alphabetical Index


Drug Information of Carbidopa and Levodopa

Product NDC: 0378-1133
Proprietary Name: Carbidopa and Levodopa
Non Proprietary Name: carbidopa and levodopa
Active Ingredient(s): 25; 250    mg/1; mg/1 & nbsp;   carbidopa and levodopa
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Carbidopa and Levodopa

Product NDC: 0378-1133
Labeler Name: Mylan Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA090324
Marketing Category: ANDA
Start Marketing Date: 20121206

Package Information of Carbidopa and Levodopa

Package NDC: 0378-1133-01
Package Description: 100 TABLET in 1 BOTTLE, PLASTIC (0378-1133-01)

NDC Information of Carbidopa and Levodopa

NDC Code 0378-1133-01
Proprietary Name Carbidopa and Levodopa
Package Description 100 TABLET in 1 BOTTLE, PLASTIC (0378-1133-01)
Product NDC 0378-1133
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name carbidopa and levodopa
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20121206
Marketing Category Name ANDA
Labeler Name Mylan Pharmaceuticals Inc.
Substance Name CARBIDOPA; LEVODOPA
Strength Number 25; 250
Strength Unit mg/1; mg/1
Pharmaceutical Classes Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA]

Complete Information of Carbidopa and Levodopa


General Information